Suchergebnisse - "Ogata, Hiraku"

PubPharm (22)

1

Impact of TKI Switching, Reduction, and Discontinuation on Cardiovascular Events in cml patients

enthalten in: ResearchSquare.com | 2023

von Sato, N. | Guo, Y. | Nakamura, H. | +8

2

Disseminated cutaneous hyalohyphomycosis caused by Fusarium proliferatum in a patient with aplastic anemia

enthalten in: The Journal of dermatology | 2023

von Suzuki, H. | Hashimoto, T. | Sugiura, R. | +5

3

Development of intravascular large B-cell lymphoma during prophylactic antibiotic treatment for anti-interferon-gamma autoantibody syndrome : A case report

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2022

von Tanigaki, T. | Kimizuka, Y. | Maki, Y. | +15

4

Primary cutaneous diffuse large B-cell lymphoma, leg type with MYC/BCL2/BCL6 overexpression

enthalten in: EJHaem | 2022

von Okada, Y. | Sone, T. | Takada, K. | +3

5

Isolated central nervous system relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia during ponatinib maintenance therapy

enthalten in: Rinsho ketsueki] The Japanese journal of clinical hematology | 2022

von Kemmoku, E. | Kawamura, T. | Ogata, H. | +5

6

Primary cutaneous diffuse large B‐cell lymphoma, leg type with MYC/BCL2/BCL6 overexpression

enthalten in: eJHaem | 2022

von Okada, Y. | Sone, T. | Takada, K. | +3

7

Spontaneous resolution of refractory ascites in the late phase after cord blood transplantation in acute myeloid leukemia

enthalten in: Rinsho ketsueki] The Japanese journal of clinical hematology | 2021

von Kawamura, T. | Teramoto, M. | Sone, T. | +8

8

Bendamustine and rituximab combination therapy for recurrent indolent B-cell lymphomas : a retrospective single-institution study

enthalten in: Rinsho ketsueki] The Japanese journal of clinical hematology | 2020

von Teramoto, M. | Sone, T. | Takada, K. | +14

9

Successful Control of Dasatinib-related Chylothorax by the Japanese Herbal Medicine "Goreisan"

enthalten in: Internal medicine (Tokyo, Japan) | 2019

von Sasaki, H. | Kimizuka, Y. | Ogata, H. | +11

10

Increased SLAMF7high monocytes in myelofibrosis patients harboring JAK2V617F provide a therapeutic target of elotuzumab

enthalten in: Blood | 2019

von Maekawa, T. | Kato, S. | Kawamura, T. | +26

CommentIn: Blood. 2019 Sep 5;134(10):789-791. - PMID 31488456